Insight Molecular Diagnostics (IMDX) News
NASDAQ: IMDXHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IMDX news summary
We found 8 recent headlines mentioning Insight Molecular Diagnostics (IMDX): 7 in the past week and 7 in the past 30 days, most often from Nasdaq, GlobeNewswire. IMDX is making an outsized move today, up 18.67% at $1.97, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Healthcare Stocks In Focus - ITOC +17%, EVAX +13%, IMDX +10%; AKAN And EVH See Trading Activity", was published by Nasdaq on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Insight Molecular Diagnostics headlines
- Healthcare Stocks In Focus - ITOC +17%, EVAX +13%, IMDX +10%; AKAN And EVH See Trading Activity(RTTNews) - Shares of several healthcare and biotechnology companies drew investor attention amid volatile trading, clinical and business developments, and analyst activity. iTonic Holdings extended…NasdaqAKAN, EVAX, EVH, IMDX
- iMDx Expands GraftAssure Utilization as First Patient Samples Arrive for GALACTIC Registry StudyNASHVILLE, Tenn., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that the first several patients have been enrolled in its GALACTIC ( G…GlobeNewswire
- Biotech Stocks Move Higher - VIVS +120%, POAS +29%, INSM +19%, ICU +7%, IMDX +9%(RTTNews) - Shares of several biotechnology and healthcare companies moved higher on Thursday amid corporate agreements, acquisition reports and renewed trading activity. VivoSim Labs surged after…NasdaqICU, IMDX, INSM, POAS
- Insight Molecular Diagnostics Inc. Announces Pricing of $15 Million Public OfferingOn November 17, 2026, Insight Molecular Diagnostics Inc. entered into an underwriting agreement with Lake Street Capital Markets, LLC, as underwriter, relating to an underwritten public offering of…Nasdaq
- Insight Molecular (IMDX) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- IMDx Reports Third Quarter 2026 Results and Provides Corporate UpdateNASHVILLE, Tenn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., iMDx, (Nasdaq: IMDX), today published the following letter to shareholders in conjunction with its third…GlobeNewswire
- Insight Molecular Diagnostics Announces Proposed Public OfferingNASHVILLE, Tenn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) (“iMDx,” “we,” “us,” “our,” or the “Company”) today announced that it has commenced an…GlobeNewswire
- iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx LaunchNASHVILLE, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced the appointment of Donnie Purto as Senior Vice President of Sales to lead the…GlobeNewswire